Home/Filings/4/0001415889-24-006414
4//SEC Filing

Lennon David James 4

Accession 0001415889-24-006414

CIK 0001422142other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:15 PM ET

Size

11.5 KB

Accession

0001415889-24-006414

Insider Transaction Report

Form 4
Period: 2024-03-01
Lennon David James
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2024-03-01+30,76830,768 total
    Exercise: $1.92Exp: 2034-03-01Common Stock (30,768 underlying)
  • Award

    Stock Option (right to buy)

    2024-03-01+130,000130,000 total
    Exercise: $1.92Exp: 2034-03-01Common Stock (130,000 underlying)
  • Award

    Restricted Stock Units

    2024-03-01+65,00065,000 total
    Common Stock (65,000 underlying)
Footnotes (4)
  • [F1]One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance.
  • [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024.
  • [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
  • [F4]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

Issuer

Aadi Bioscience, Inc.

CIK 0001422142

Entity typeother

Related Parties

1
  • filerCIK 0001995275

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:15 PM ET
Size
11.5 KB